Sartorius Stedim Biotech's total assets for Q2 2025 were €8.31B, an increase of 0.11% from the previous quarter. FR:DIM total liabilities were €4.27B for the fiscal quarter, a -0.52% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.